Merck (MRK) Non Operating Income (2009 - 2026)
Merck (MRK) reported Non Operating Income of -$138.0 million for Q1 2026, down 494.29% year-over-year from $35.0 million in Q1 2025, and up 68.06% on a QoQ basis from -$432.0 million in Q4 2025.
Merck (MRK) has 18 years of Non Operating Income data on file, last reported at -$138.0 million in Q1 2026.
- Quarterly Non Operating Income fell 494.29% year-over-year to -$138.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$325.0 million (down 1260.71% YoY) and the FY2025 annual result came in at -$151.0 million, down 729.17% from the prior year.
- Non Operating Income grew to -$138.0 million in Q1 2026 per MRK's latest filing, from -$432.0 million in the prior quarter.
- Across five years, Non Operating Income topped out at $238.0 million in Q3 2025 and bottomed at -$708.0 million in Q1 2022.
- The 5-year median for Non Operating Income is -$89.0 million (2023), against an average of -$131.1 million.
- The widest annual swing landed in 2022, when Non Operating Income tumbled 525.24%; it then surged 228.57% in 2024.
- Tracing MRK's Non Operating Income over 5 years: stood at $75.0 million in 2022, then tumbled by 204.0% to -$78.0 million in 2023, then plunged by 62.82% to -$127.0 million in 2024, then plunged by 240.16% to -$432.0 million in 2025, then jumped by 68.06% to -$138.0 million in 2026.
- Per Business Quant, the three latest MRK Non Operating Income figures stand at -$138.0 million (Q1 2026), -$432.0 million (Q4 2025), and $238.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | -65.00 Mn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | -294.00 Mn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -2.31 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -138.00 Mn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 75.00 Mn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 235.00 Mn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -861.00 Mn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -32.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -138.00 Mn |
| Dec 31, 2025 | -432.00 Mn |
| Sep 30, 2025 | 238.00 Mn |
| Jun 30, 2025 | 7.00 Mn |
| Mar 31, 2025 | 35.00 Mn |
| Dec 31, 2024 | -127.00 Mn |
| Sep 30, 2024 | 162.00 Mn |
| Jun 30, 2024 | -42.00 Mn |
| Mar 31, 2024 | 33.00 Mn |
| Dec 31, 2023 | -78.00 Mn |
| Sep 30, 2023 | -126.00 Mn |
| Jun 30, 2023 | -172.00 Mn |
| Mar 31, 2023 | -89.00 Mn |
| Dec 31, 2022 | 75.00 Mn |
| Sep 30, 2022 | -429.00 Mn |
| Jun 30, 2022 | -438.00 Mn |
| Mar 31, 2022 | -708.00 Mn |
| Dec 31, 2021 | 334.00 Mn |
| Sep 30, 2021 | 450.00 Mn |
| Jun 30, 2021 | 103.00 Mn |
| Mar 31, 2021 | 455.00 Mn |
| Dec 31, 2020 | 253.00 Mn |
| Sep 30, 2020 | 312.00 Mn |
| Jun 30, 2020 | 387.00 Mn |
| Mar 31, 2020 | -71.00 Mn |
| Dec 31, 2019 | 233.00 Mn |
| Sep 30, 2019 | -35.00 Mn |
| Jun 30, 2019 | -140.00 Mn |
| Mar 31, 2019 | -188.00 Mn |
| Dec 31, 2018 | -110.00 Mn |
| Sep 30, 2018 | 172.00 Mn |
| Jun 30, 2018 | 48.00 Mn |
| Mar 31, 2018 | 291.00 Mn |
| Dec 31, 2017 | 149.00 Mn |
| Sep 30, 2017 | 207.00 Mn |
| Jun 30, 2017 | 73.00 Mn |
| Mar 31, 2017 | 71.00 Mn |
| Dec 31, 2016 | -101.00 Mn |
| Sep 30, 2016 | -22.00 Mn |
| Jun 30, 2016 | -19.00 Mn |
| Mar 31, 2016 | -48.00 Mn |
| Dec 31, 2015 | -903.00 Mn |
| Sep 30, 2015 | 170.00 Mn |
| Jun 30, 2015 | -739.00 Mn |
| Mar 31, 2015 | -55.00 Mn |
| Dec 31, 2014 | 10.64 Bn |
| Sep 30, 2014 | 166.00 Mn |
| Jun 30, 2014 | 650.00 Mn |
| Mar 31, 2014 | 163.00 Mn |
| Dec 31, 2013 | 245.00 Mn |
| Sep 30, 2013 | -172.00 Mn |
| Jun 30, 2013 | -201.00 Mn |
| Mar 31, 2013 | -282.00 Mn |
| Dec 31, 2012 | -670.00 Mn |
| Sep 30, 2012 | -200.00 Mn |
| Jun 30, 2012 | -103.00 Mn |
| Mar 31, 2012 | -142.00 Mn |
| Dec 31, 2011 | -137.00 Mn |
| Sep 30, 2011 | -66.00 Mn |
| Jun 30, 2011 | -121.00 Mn |
| Mar 31, 2011 | -622.00 Mn |
| Dec 31, 2010 | -309.00 Mn |
| Sep 30, 2010 | -1.11 Bn |
| Jun 30, 2010 | 281.00 Mn |
| Mar 31, 2010 | -167.00 Mn |
| Dec 31, 2009 | 7.81 Bn |
| Sep 30, 2009 | 2.79 Bn |
| Jun 30, 2009 | -3.60 Mn |
| Mar 31, 2009 | 67.20 Mn |